These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 9291119)

  • 1. Logical analysis of timing-dependent receptor signalling specificity: application to the insulin receptor metabolic and mitogenic signalling pathways.
    Shymko RM; De Meyts P; Thomas R
    Biochem J; 1997 Sep; 326 ( Pt 2)(Pt 2):463-9. PubMed ID: 9291119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Timing-dependence of insulin-receptor mitogenic versus metabolic signalling: a plausible model based on coincidence of hormone and effector binding.
    Shymko RM; Dumont E; De Meyts P; Dumont JE
    Biochem J; 1999 May; 339 ( Pt 3)(Pt 3):675-83. PubMed ID: 10215607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitogenic properties of insulin and insulin analogues mediated by the insulin receptor.
    Ish-Shalom D; Christoffersen CT; Vorwerk P; Sacerdoti-Sierra N; Shymko RM; Naor D; De Meyts P
    Diabetologia; 1997 Jul; 40 Suppl 2():S25-31. PubMed ID: 9248698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of binding proteins to IRS-1 in insulin signalling.
    Ogawa W; Matozaki T; Kasuga M
    Mol Cell Biochem; 1998 May; 182(1-2):13-22. PubMed ID: 9609110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Timing-dependent modulation of insulin mitogenic versus metabolic signalling.
    De Meyts P; Shymko RM
    Novartis Found Symp; 2000; 227():46-57; discussion 57-60. PubMed ID: 10752064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Minimizing Mitogenic Potency of Insulin Analogues Through Modification of a Disulfide Bond.
    Ong SC; Belgi A; Merriman AL; Delaine CA; van Lierop B; Andrikopoulos S; Robinson AJ; Forbes BE
    Front Endocrinol (Lausanne); 2022; 13():907864. PubMed ID: 35832429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oleoylethanolamide, a natural ligand for PPAR-alpha, inhibits insulin receptor signalling in HTC rat hepatoma cells.
    Martínez de Ubago M; García-Oya I; Pérez-Pérez A; Canfrán-Duque A; Quintana-Portillo R; Rodríguez de Fonseca F; González-Yanes C; Sánchez-Margalet V
    Biochim Biophys Acta; 2009 Aug; 1791(8):740-5. PubMed ID: 19345745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deciphering Brain Insulin Receptor and Insulin-Like Growth Factor 1 Receptor Signalling.
    Kleinridders A
    J Neuroendocrinol; 2016 Nov; 28(11):. PubMed ID: 27631195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin and IGF-1 receptor trafficking and signalling.
    Foti M; Moukil MA; Dudognon P; Carpentier JL
    Novartis Found Symp; 2004; 262():125-41; discussion 141-7, 265-8. PubMed ID: 15562826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of intracellular signalling by insulin and the hypermitogenic AspB10 analogue in MCF-7 breast adenocarcinoma cells.
    Oleksiewicz MB; Bonnesen C; Hegelund AC; Lundby A; Holm GM; Jensen MB; Krabbe JS
    J Appl Toxicol; 2011 May; 31(4):329-41. PubMed ID: 20936651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. c-Abl and insulin receptor signalling.
    Genua M; Pandini G; Cassarino MF; Messina RL; Frasca F
    Vitam Horm; 2009; 80():77-105. PubMed ID: 19251035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin glargine and receptor-mediated signalling: clinical implications in treating type 2 diabetes.
    Le Roith D
    Diabetes Metab Res Rev; 2007 Nov; 23(8):593-9. PubMed ID: 17922476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stimulation of pancreatic beta-cell proliferation by growth hormone is glucose-dependent: signal transduction via janus kinase 2 (JAK2)/signal transducer and activator of transcription 5 (STAT5) with no crosstalk to insulin receptor substrate-mediated mitogenic signalling.
    Cousin SP; Hügl SR; Myers MG; White MF; Reifel-Miller A; Rhodes CJ
    Biochem J; 1999 Dec; 344 Pt 3(Pt 3):649-58. PubMed ID: 10585851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binding of SH2 containing proteins to the insulin receptor: a new way for modulating insulin signalling.
    Liu F; Roth RA
    Mol Cell Biochem; 1998 May; 182(1-2):73-8. PubMed ID: 9609116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bradykinin signalling to MAP kinase: cell-specific connections versus principle mitogenic pathways.
    Liebmann C
    Biol Chem; 2001 Jan; 382(1):49-55. PubMed ID: 11258671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphoinositide signalling pathways in metabolic regulation.
    Foukas LC; Withers DJ
    Curr Top Microbiol Immunol; 2010; 346():115-41. PubMed ID: 20517721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LMW-PTP is a negative regulator of insulin-mediated mitotic and metabolic signalling.
    Chiarugi P; Cirri P; Marra F; Raugei G; Camici G; Manao G; Ramponi G
    Biochem Biophys Res Commun; 1997 Sep; 238(2):676-82. PubMed ID: 9299573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic, anabolic, and mitogenic insulin responses: A tissue-specific perspective for insulin receptor activators.
    Bedinger DH; Adams SH
    Mol Cell Endocrinol; 2015 Nov; 415():143-56. PubMed ID: 26277398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Colocalization of insulin receptor and insulin receptor substrate-1 to caveolae in primary human adipocytes. Cholesterol depletion blocks insulin signalling for metabolic and mitogenic control.
    Karlsson M; Thorn H; Danielsson A; Stenkula KG; Ost A; Gustavsson J; Nystrom FH; Strålfors P
    Eur J Biochem; 2004 Jun; 271(12):2471-9. PubMed ID: 15182363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic engineering in mice: impact on insulin signalling and action.
    Lamothe B; Baudry A; Desbois P; Lamotte L; Bucchini D; De Meyts P; Joshi RL
    Biochem J; 1998 Oct; 335 ( Pt 2)(Pt 2):193-204. PubMed ID: 9761714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.